Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018
oleh: Brigg Reilley, Matt Miller, Matt Hudson, Rick Haverkate, Jessica Leston
| Format: | Article |
|---|---|
| Diterbitkan: | BMC 2019-12-01 |
Deskripsi
Abstract Medicaid, the state-level public insurance in the United States, has widely differing criteria treatment for hepatitis C virus (HCV) such as stage of liver fibrosis, documented sobriety, and specialist consultation. In a rural health network, facilities located in two less restrictive states prescribed HCV drugs at a significantly higher rate than two more restrictive states (rate ratio 4.7, CI 2.6–8.5). Prescription rates per population were highly associated with HCV treatment policies.